Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
This compounded preparation: - Has not been approved by the FDA - Has not undergone FDA review for safety, effectiveness, or quality - Is prepared specifically for you based on your prescriber's order - Individual outcomes may vary Compounded medications are not subject to FDA approval and lack the same safety and efficacy data as FDA-approved commercial medications
R., Salehi, M., & Jabari, A
Other oral antidiabetic medications, including SGLT2 inhibitors and DPP-4 inhibitors, are generally not recommended during breastfeeding due to limited safety data
Exendin-4 reduces tau hyperphosphorylation in type 2 diabetic rats via increasing brain insulin level
A., Josse, R
US$ 28.62
US$ 29.61
US$ 20.13
